The aim of this serological survey was to assess the persistence of measles antibodies among health care workers (HCWs) at risk of incidental measles. A prospective study of measles-specific antibodies in serum samples obtained from a total of 2782 participants aged 19-89 years was conducted between May 2018 and December 2019. The seropositivity rate of 93.7% (95% CI: 92.4-94.9%) in fully vaccinated participants aged 19-48 years was significantly lower than that of 98.0% (95% CI: 96.5-99.0%) in participants naturally immunised before 54 years. A cohort of those born in 1971-1975, vaccinated predominantly with one dose, showed lower seropositivity persistence (86.6%) than those fully vaccinated with two doses or naturally immunised. Otherwise, seropositivity was not markedly influenced by sex, age, smoking status, overweight, obesity or concomitant disease. The presence of sufficient antibody levels in a high proportion of HCWs irrespective of the way they acquired immunity is a favourable finding for managing incidental measles; hence, in the presence of a risk of a measles outbreak, it would be possible to perform targeted vaccination of only at-risk HCWs with a history of incomplete vaccination or missing information about the way in which immunity is acquired.

3rd Faculty of Medicine Charles University Prague 10000 Prague Czech Republic

Faculty Hospital Kralovské Vinohrady 10000 Prague Czech Republic

Zobrazit více v PubMed

Measles (Rubeola) Centers of Disease Control and Prevention. [(accessed on 3 June 2020)]; Available online: https://www.cdc.gov/measles/index.html.

Nandy R., Handzel T., Zaneidou M., Biey J., Coddy R.Z., Perry R., Strebel P., Cairns L. Case-Fatality Rate during a Measles Outbreak in Eastern Niger in 2003. Clin. Infect. Dis. 2006;42:322–328. doi: 10.1086/499240. PubMed DOI

Wolfson L.J., Grais R.F., Luquero F.J., Birmingham M.E., Strebel P.M. Estimates of measles case fatality ratios: A comprehensive review of community-based studies. Int. J. Epidemiol. 2009;38:192–205. doi: 10.1093/ije/dyn224. PubMed DOI

World Health Organization Vaccine-Preventable Diseases: Monitoring System. 2019 Global Summary fo the Czech Republic. [(accessed on 2 June 2020)]; Available online: https://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=CZE&commit=OK.

Tafuri S., Germinario C., Rollo M., Prato R. Occupational risk from measles in healthcare personnel: A case report. J. Occup. Health. 2008;51:97–99. doi: 10.1539/joh.N8006. PubMed DOI

Botelho-Nevers E., Cassir N., Minodier P., Laporte R., Gautret P., Badiaga S., Thiberville D.J., Ninove L., Charrel R., Brouqui P. Measles among healthcare workers: A potential for nosocomial outbreaks. Eur. Surveill. 2011;16:19764. PubMed

Sydnor E.R., Perl T.M. Healthcare providers as sources of vaccine-preventable diseases. Vaccine. 2014;32:4814–4822. doi: 10.1016/j.vaccine.2014.03.097. PubMed DOI

Coppeta L., Pietroiusti A., Lieto P., Ferraro M., Grelli S., Stillo M., Magrini A. Measles immunity in an Italian teaching hospital. Occup. Med. 2018;69:143–145. doi: 10.1093/occmed/kqy132. PubMed DOI

Urbiztondo L., Borras E., Costa J., Broner S., Campins M., Bayas J.M., Esteve M., Domínguez-Berjón M.F. Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era. BMC Infect. Dis. 2013;13:391. doi: 10.1186/1471-2334-13-391. PubMed DOI PMC

Kumakura S., Shibata H., Onoda K., Nishimura N., Matsuda C., Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: Sex, age, occupational-Related differences and vaccine efficacy. Epidemiol. Infect. 2013;142:12–19. doi: 10.1017/S0950268813000393. PubMed DOI PMC

World Health Organization Measles Virus Vaccine: WHO Position Paper. Wkly. Epidemiol. Rec. 2009;84:349–360. PubMed

González-Escalada A., García-García L., Viguera-Ester P., Marin-Garcia P., García J., Gil-De-Miguel A., Gil Prieto R. Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain. Hum. Vaccines Immunother. 2013;9:1918–1925. doi: 10.4161/hv.25127. PubMed DOI PMC

Mollema L., Smits G.P., Berbers G.A., Van Der Klis F.R., Van Binnendijk R.S., De Melker H.E., Hahné S.J.M. High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands. Epidemiol. Infect. 2013;142:1100–1108. doi: 10.1017/S0950268813001532. PubMed DOI PMC

Tomaskova H., Zelena H., Kloudová A., Tomášek I. Serological survey of measles immunity in the Czech Republic, 2013. Cent. Eur. J. Public Health. 2018;26:22–27. doi: 10.21101/cejph.a5251. PubMed DOI

Rota M.C., Massari M., Gabutti G., Guido M., De Donno A., Degli Atti M.L.C. Measles serological survey in the Italian population: Interpretation of results using mixture model. Vaccine. 2008;26:4403–4409. doi: 10.1016/j.vaccine.2008.05.094. PubMed DOI

Bechini A., Boccalini S., Tiscione E., Pesavento G., Mannelli F., Peruzzi M., Rapi S., Mercurio S., Bonanni P. Progress towards measles and rubella elimination in Tuscany, Italy: The role of population seroepidemiological profile. Eur. J. Public Health. 2010;22:133–139. doi: 10.1093/eurpub/ckq134. PubMed DOI

Anichini G., Gandolfo C., Fabrizi S., Miceli G., Terrosi C., Savellini G.G., Prathyumnan S., Orsi D., Battista G., Cusi M.G. Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines. 2020;8:66. doi: 10.3390/vaccines8010066. PubMed DOI PMC

Mossong J., Muller C.P. Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine. 2003;21:4597–4603. doi: 10.1016/S0264-410X(03)00449-3. PubMed DOI

Krugman S. Further-Attenuated Measles Vaccine: Characteristics and Use. Clin. Infect. Dis. 1983;5:477–481. doi: 10.1093/clinids/5.3.477. PubMed DOI

Gonçalves G., Frade J., Nunes C., Mesquita J.R., Nascimento M.S.J. Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal. Vaccine. 2015;33:5057–5063. doi: 10.1016/j.vaccine.2015.08.057. PubMed DOI

Laksono B.M., De Vries R.D., Verburgh R.J., Visser E.G., De Jong A., Fraaij P.L.A., Ruijs W.L.M., Nieuwenhuijse D.F., Ham H.-J.V.D., Koopmans M.P.G., et al. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat. Commun. 2018;9:4944. doi: 10.1038/s41467-018-07515-0. PubMed DOI PMC

Diaz-Ortega J.-L., Forsey T., Clements C., Milstien J. The Relationship Between Dose and Response of Standard Measles Vaccines. Biologicals. 1994;22:35–44. doi: 10.1006/biol.1994.1006. PubMed DOI

Report of a Collaborative Study to Assess the Suitability of a Replacement for the 2nd International Standard for Anti-Measles Serum. [(accessed on 2 May 2020)]; World Health Organization. Available online: https://apps.who.int/iris/handle/10665/70612.

Seroprevalence of Measles Antibodies in the Population of the Olomouc Region, Czech Republic-Comparison of the Results of Four Laboratories